| Krebs Biochemicals & Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524518 |
NSE Symbol : KREBSBIO |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE268B01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -73.15 |
Market Cap(₹Cr) : 148.85 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 4.17 | 5.48 | 6.10 | 11.47 | 12.86 | 12.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 4.17 | 5.48 | 6.10 | 11.47 | 12.86 | 12.89 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.01 | 0.01 | 0.34 | 0.25 | 0.09 | 0.03 |
| Total Income | 4.17 | 5.49 | 6.44 | 11.72 | 12.94 | 12.92 |
| Total Expenditure | 6.96 | 7.57 | 11.51 | 16.18 | 15.57 | 15.09 |
| PBIDT | -2.79 | -2.08 | -5.07 | -4.46 | -2.62 | -2.16 |
| Interest | 1.73 | 1.65 | 1.61 | 1.56 | 1.42 | 1.32 |
| PBDT | -4.52 | -3.73 | -6.68 | -6.02 | -4.05 | -3.48 |
| Depreciation | 1.62 | 1.60 | 1.57 | 1.72 | 1.71 | 1.69 |
| Tax | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -6.14 | -5.32 | -8.27 | -7.74 | -5.76 | -5.17 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -6.14 | -5.32 | -8.27 | -7.74 | -5.76 | -5.17 |
| EPS (Unit Curr.) | -2.85 | -2.47 | -3.83 | -3.59 | -2.67 | -2.40 |
| EPS (Adj) (Unit Curr.) | -2.85 | -2.47 | -3.83 | -3.59 | -2.67 | -2.40 |
| Calculated EPS (Unit Curr.) | -2.85 | -2.47 | -3.83 | -3.59 | -2.67 | -2.40 |
| Calculated EPS (Adj) (Unit Curr.) | -2.85 | -2.47 | -3.83 | -3.59 | -2.67 | -2.40 |
| Calculated EPS (Ann.) (Unit Curr.) | -11.40 | -9.88 | -15.34 | -14.36 | -10.69 | -9.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -11.40 | -9.88 | -15.34 | -14.36 | -10.69 | -9.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 | 21.56 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -66.91 | -37.96 | -83.11 | -38.88 | -20.37 | -16.76 |
| PBDTM(%) | -108.39 | -68.07 | -109.51 | -52.48 | -31.49 | -27.00 |
| PATM(%) | -147.24 | -97.08 | -135.57 | -67.48 | -44.79 | -40.11 |